12223 results for "playerauctions fc 26 Visit Buyfc26coins.com for latest FC 26 coins news..HXSQ"

in 12.09 milliseconds.

• DATA FILES FOR SJAMLM7

  DATA FILES FOR SJAMLM7

  Dataset EGAD00001000259

• "Usage of small amounts of DNA for Illumina sequencing"

  "Usage of small amounts of DNA for Illumina sequencing"

  Dataset EGAD00001000034

• DATA FILES FOR Histone Capture bams

  DATA FILES FOR Histone Capture bams

  Dataset EGAD00001000657

• WGS and WXS files for Dyer ATRX study

  WGS and WXS files for Dyer ATRX study

  Dataset EGAD00001003389

• DATA FILES FOR PCGP SJETP WXS

  DATA FILES FOR PCGP SJETP WXS

  Dataset EGAD00001001248

• Australian genomes

  Mapped data (bam files) for high-throughput whole genome sequence data for 83 modern Aboriginal Australians

  Dataset EGAD00001002001

• DAC for CTOS colorectal cancer organoids

  This Data Access Committee (DAC) is responsible for reviewing and approving access requests to controlled-access human sequencing data generated from colorectal cancer patient-derived organoids established using the CTOS method. The dataset includes whole-exome sequencing (WES) and RNA sequencing (RNA-seq) data. Access requests are evaluated for consistency with the original informed consent and the approved research purposes.

  Dac EGAC50000000915

• WTCCC2 case-control study for Ulcerative Colitis

  WTCCC2 project genome-wide case-control association study for Ulcerative Colitis (UC) using the 1958 British Birth Cohort and the UK National Blood Service collections as controls.

  Study EGAS00000000084

• Data from Shea et al Can Research 2025

  This dataset contains single cell RNA sequencing (192 fastq files for 59 samples), whole exome sequencing (20 BAM files -hg38- for 20 samples) and bulk RNA sequencing (138 paired-end fastq files and 17 single-end fastq files for 8 samples)

  Dataset EGAD50000001334

• FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human HSCs

  bulk RNA sequencing of AML patients It contains 18 samples from primary AML patients. Half of the samples are control samples and half of the samples are FLT3-ITD knock-out (edited for the FLT3-ITD mutation). It is using Illumina high-throughput technology

  Dataset EGAD50000000636